APARITO
Aparito’s mission is to digitise clinical trials and accelerate drug development by supporting patient-centric clinical trials with the Atom5™ eCOA platform. The Atom5™ platform is Part 11, GDPR and HIPPA compliant and supports clinical trials at scale with video eCOAs, ePROs, Wearables, Telemedicine and eConsent in 193 countries and 125 languages to capture more frequent patient-generated data in the clinic and at home. This moves from relying on sterile, snapshot assessments during clinic visits to continuous, real-time, real-world data utilising novel eCOA and digital biomarkers.
APARITO
Industry:
Clinical Trials Health Care Medical
Founded:
2014-10-01
Address:
Wrexham, Wrexham, United Kingdom
Country:
United Kingdom
Website Url:
http://www.aparito.com
Total Employee:
11+
Status:
Active
Contact:
+44 1978 896 191
Email Addresses:
[email protected]
Total Funding:
1.02 M GBP
Technology used in webpage:
Domain Not Resolving Person Schema Gravatar Profiles
Similar Organizations
Ansun BioPharma
Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of host-directed anti-viral.
Campus des Technologies de la Santé/CTS Healthcare
CTS Healthcare provides services to promote the growth and development of companies in the medical sector
Coriell Life Sciences
Coriell Life Sciences delivers the power of precision medicine using pharmacogenomics and clinical decision support software.
Hoth Intelligence
Seeing is everything. We use augmented reality to make healthcare better.
myTomorrows
myTomorrows is a global platform that connects patients with unmet medical needs to treatments in development around the world.
Perceiv AI
AI-driven precision medicine, forecasting disease progression
Phrase Health
Phrase Health is empowering teams with EHR data and collaborative tools that drive improved clinical outcomes.
CardioSignal
Cardiac monitoring via smartphone
Current Employees Featured
Founder
Investors List
Wealth Club
Wealth Club investment in Seed Round - Aparito
Bethnal Green Ventures
Bethnal Green Ventures investment in Seed Round - Aparito
Bayer
Bayer investment in Seed Round - Aparito
DigitalHealth.London Accelerator
DigitalHealth.London Accelerator investment in Seed Round - Aparito
MassChallenge
MassChallenge investment in Non Equity Assistance - Aparito
Bethnal Green Ventures
Bethnal Green Ventures investment in Pre Seed Round - Aparito
Official Site Inspections
http://www.aparito.com Semrush global rank: 5.48 M Semrush visits lastest month: 1.34 K
- Host name: ec2-54-228-80-7.eu-west-1.compute.amazonaws.com
- IP address: 54.228.80.7
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
- Postal: D02
More informations about "Aparito"
About Aparito, a wholly owned subsidiary of Eli Lilly …
Aparito was founded by Dr. Elin Haf Davies in 2014 to empower patients in the drug development pathway and transform how clinical studies are conducted and novel eCOAs are developed. Initially designed for rare diseases, Aparito’s …See details»
Aparito - Crunchbase Company Profile & Funding
Aparito may be growing as it has been shortlisted in the Wales STEM Awards 2023, which indicates recognition in the field of science, technology, …See details»
Aparito - a wholly owned subsidiary of Eli Lilly and …
Aparito’s mission is to digitise clinical trials and accelerate drug development for patients with life-limiting diseases by supporting patient-centric clinical trials.See details»
Aparito - Org Chart, Teams, Culture & Jobs - The Org
View Aparito's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
APARITO LIMITED overview - Find and update company …
Nov 1, 2020 People for APARITO LIMITED (09285366) More for APARITO LIMITED (09285366) Registered office address Unit 11 Wrexham Technology Park, Wrexham, Wales, LL13 7YP . …See details»
Aparito - Leadership Team - The Org
The Leadership Team at Aparito, comprising the Chief Operations Officer, Chief Executive Officer, Chief Marketing Officer, and Chief Scientific Officer, drives strategic vision and operational …See details»
Aparito - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... Non Equity Assistance - …See details»
Aparito - Crunchbase
Aparito focuses on digitizing clinical trials and capturing real-world data, while Coriell Life Sciences and myTomorrows connect patients with treatments. Phrase Health empowers …See details»
Aparito 2025 Company Profile: Valuation, Investors, …
When was Aparito founded? Aparito was founded in 2014. Where is Aparito headquartered? Aparito is headquartered in Wrexham, United Kingdom. What is the size of Aparito? Aparito has 30 total employees. What industry is Aparito …See details»
Aparito is now a wholly owned subsidiary of Eli Lilly and Company
+44 1978 896 191 11 Gwenfro Technology Park Croesnewydd Road Wrexham LL13 7YPSee details»
Aparito | ClinEco
Aparito’s mission is to digitise clinical trials and accelerate drug development for patients living with life-limiting diseases by supporting patient-centric clinical trials for those needing access …See details»
Aparito - Ascension
Aparito digitises clinical trials and captures real-world data through mobile apps, video assessments & wearable devices. They capture multiple, high-frequency data points from …See details»
Aparito Company Profile: Funding, Investors & Partnerships
Aparito is a global health tech company that brings clinical trials to patients and unlocks real-world data through mobile apps, video assessments & wearable devices. We offer patient-centric …See details»
Aparito - Sinodo Surgical Sutures
Aparito’s mission is to digitise clinical trials and accelerate drug development by supporting patient-centric clinical trials with the Atom5â„¢ eCOA platform. The Atom5â„¢ platform is Part …See details»
Eli Lilly acquires Aparito - 2024-07-11 - Crunchbase
Jul 11, 2024 Aparito Aparito digitise clinical trials and capture real-world data through our eCOA platform using video assessments, wearable devices and ePROs Acquiring Organization: Eli …See details»
BGV Blog - 10 Questions with Aparito
Jun 25, 2021 Welcome to the first edition of our new blog series '10 Questions with…' where we sit down with founders from our portfolio to shed more light on their journeys of founding and …See details»
Aparito - Digital Playbook
Aparito’s patient-generated data platform is disease-agnostic and scalable, ready for rapid deployment in global rare disease studies. Key Facts. Studies live in over 20 countries and 18 …See details»
Aparito - Better Society Capital
Aparito was quick to respond to the crisis as its existing technology lends itself to supporting routine clinical care remotely. Having partnered with Betsi Cadwaladr University Health Board …See details»
Clinical Portal - Aparito
The portal enables clinicians to upload clinical data to the system and communicate directly with individual patients. All patient captured data can be viewed by sponsors and/or CROs in real …See details»
Par funding CEO sentenced to 15 and a half years in prison for …
March 26, 2025 — United States Attorney David Metcalf announced that Joseph LaForte of Philadelphia, Pennsylvania, was sentenced today by United States District Court Judge Mark …See details»